Statistics for Catalyst Pharmaceuticals (id:5261 CPRX)

Valuation metrics

Market cap

2.48B

Enterprise value

2.02B

Trailing P/E (ttm)

17.64

Forward P/E

13.79

PEG ratio

13.79

Price/Sales (ttm)

5.39

Price/Book (mrq)

3.76

Enterprise Value/Revenue

4.38

Enterprise Value/EBITDA

9.54

Overview

Shares outstanding

119.27M

Float

103.02M

Shares short

6.01M

% Held by insiders

0.06%

% Held by institutions

0.82%

Average volume (10 days)

1.52M

Average volume (90 days)

Price summary

52-Week low

13.00

52-Week high

24.27

52-Week change

34.54%

Beta

0.76

50-Day moving average

20.99

200-Day moving average

17.42

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

31.01%

Operating margin

39.56%

Operational effectiveness

Return on assets

18.35%

Return on equity

28.29%

Income statement

Revenue (ttm)

4.00

Revenue per share (ttm)

4.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

346.24M

EBITDA

211.94M

Net income to common (ttm)

142.80M

Diluted EPS (ttm)

1.18

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

442.33M

Total cash per share (mrq)

3.71

Total debt (mrq)

3.28M

Total Debt/Equity (mrq)

0.50

Current ratio (mrq)

511.40%

Book value per share (mrq)

5.54

Cash flow

Cash flow statement

224.58M

Levered free cash flow (LFCF)

150.67M